A Multicentre, Randomized Phase III Study of Rituximab as Maintenance Treatment Versus Observation in Patients With Aggressive B-Cell Lymphoma: NHL-13

The recruitment status of this study is unknown because the information has not been verified recently.
Verified January 2009 by Arbeitsgemeinschaft medikamentoese Tumortherapie.
Recruitment status was  Active, not recruiting
Sponsor:
Collaborator:
Hoffmann-La Roche
Information provided by:
Arbeitsgemeinschaft medikamentoese Tumortherapie
ClinicalTrials.gov Identifier:
NCT00400478
First received: November 16, 2006
Last updated: January 19, 2009
Last verified: January 2009
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: December 2012
  Estimated Primary Completion Date: December 2012 (Final data collection date for primary outcome measure)